J&J Recalls 9M Tylenol Meds Over Missing Alcohol Label

Law360, New York (November 24, 2010, 4:26 PM EST) -- Pharmaceutical  maker Johnson & Johnson announced Wednesday afternoon that it would haul in 9.3 million eight-ounce bottles of Tylenol Cold Multi-Symptom medicine to update their front panels with alcohol content disclosures.  

 

The recall affects products sold in the U.S. at the wholesale and retail level by Johnson & Johnson McNeil Consumer Healthcare.

 

The company initiated the recall alongside McNeil and the U.S. Food and Drug Administration after a review revealed that alcohol included in certain flavoring agents was listed as an inactive ingredient...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.